Cellectis (CLLS) Gross Profit (QoQ) (2015 - 2023)
Cellectis (CLLS) Gross Profit (QoQ) (2015 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Cellectis |
17.40 Bn |
17.21 Bn |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
546.15% |
| Sep 30, 2023 |
-121.14% |
| Jun 30, 2023 |
163.08% |
| Mar 31, 2023 |
-564.29% |
| Dec 31, 2022 |
121.88% |
| Sep 30, 2022 |
-119.63% |
| Jun 30, 2022 |
2,956.25% |
| Mar 31, 2022 |
152.46% |
| Dec 31, 2021 |
93.23% |
| Sep 30, 2021 |
-55.88% |
| Jun 30, 2021 |
75.33% |
| Mar 31, 2021 |
22.21% |
| Dec 31, 2020 |
-83.55% |
| Sep 30, 2020 |
43.94% |
| Jun 30, 2020 |
-106.43% |
| Mar 31, 2020 |
3,804.48% |
| Dec 31, 2019 |
-129.05% |
| Sep 30, 2019 |
1,155.49% |
| Jun 30, 2019 |
-25.11% |
| Mar 31, 2019 |
81.45% |
